News

News block

Prof. dr. Dirksen CEO CTCM

23-11-2018

Prof. dr. Carmen Dirksen is from the 1st of January CEO of Clinical Trial Center Maastricht.

The Board of Directors from MUMC+ appointed her already Deputy CEO from the 1st of June 2018. In this period she fulfilled a double role at KEMTA and CTCM.

Misses Dirksen followes in de footsteps of Gemma Voss, who started the company. She is now working as CEO of Cardialysis in Rotterdam.

CTCM is very pleased with prof. dr. Dirksen as CEO. We wish her all the best of luck.